Search results
Nurix Therapeutics, With 345% Run, Posts A 'Clear Win' In Leukemia Treatment
Investor's Business Daily· 3 hours agoThe company tested its treatment, dubbed NX-5948, in patients with relapsed or refractory forms of ...
EHA 2024: Brukinsa/Venclexta for CLL/SLL lacks control arm in SEQUOIA trial
Clinical Trials Arena via Yahoo Finance· 7 hours agoThis trial evaluated the efficacy of AbbVie/Roche's Venclexta (venetoclax) and BeiGene's Brukinsa...
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? - Mustang Bio (NASDAQ:MBIO)
Benzinga· 10 hours agoMB-106 is being developed in a collaboration between Mustang and Fred Hutch Cancer Center to treat...
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket...
Benzinga· 10 hours agoShares of Nurix Therapeutics, Inc. NRIX rose sharply in today's pre-market trading after the company announced results from its ongoing clinical trial of NX-5948 in patients with relapsed refractory ...
... of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the...
Benzinga· 2 days agoNurix Therapeutics, Inc. NRIX, a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today ...
Remembering the life of Michael E. and Sandra S. (Burgess) McIntyre
Bangor Daily News· 6 days agoMichael and Sandra McIntyre passed away within hours of each other on June 8 and June 9, 2024. Sandra was born on October 14, 1949 in Farmington, Maine, to Richard and Alma Burgess. Sandra attended ...
What Is a T-Cell Lymphoproliferative Disorder? Inside Halsey's Diagnosis
Health.com· 6 days agoHalsey, 29, was diagnosed and treated for both lupus and a rare white blood cell disorder, according...
Head to Head Survey: Evaxion Biotech A/S (NASDAQ:EVAX) and Halozyme Therapeutics (NASDAQ:HALO)
ETF DAILY NEWS· 4 days agoHalozyme Therapeutics (NASDAQ:HALO – Get Free Report) and Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the ...
MD Anderson Research Highlights: EHA 2024 Special | Newswise
Newswise· 5 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research, and prevention. Thes
GENMAB A/S/S (OTCMKTS:GMXAY) and LianBio (NASDAQ:LIAN) Critical Contrast
ETF DAILY NEWS· 7 days agoLianBio (NASDAQ:LIAN – Get Free Report) and GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses ...